A Rapid PCR Test for Early Cancer Diagnosis

A Rapid PCR Test for Early Cancer Diagnosis

Biopharma A Rapid PCR Test for Early Cancer Diagnosis   A novel qPCR-based diagnostic test for detecting oral cancer risk and predicting patient prognosis. qMIDSv2 is low cost, rapid, and minimally invasive. It requires only 1mm3 of biopsy material and is applicable...
Developing inhibitors to target activated fibroblasts

Developing inhibitors to target activated fibroblasts

Biopharma Developing inhibitors to target activated fibroblasts   A drug discovery program has led to promising and selective pharmacological inhibitors of PNK2 to target activated fibroblasts in cancer and other fibrotic diseases. Deletion of PKN2 can suppress the...
A new method for detecting circulating tumour cells

A new method for detecting circulating tumour cells

Biopharma Megakaryocytes and circulating tumour cells as a cancer prognostic marker   Prostate cancer is the most common cancer in Western men and the second most frequent cause of cancer-related death. Most prostate cancer deaths are caused by metastases, which are...
Drug ranking using machine learning

Drug ranking using machine learning

Biopharma Drug ranking using machine learning   By using machine learning to rank drugs, we could revolutionise cancer treatment through offering truly personalised medicine. Selecting the best drug for individual cancer patients is complicated. Every tumour and...